Dr. Chih-Pin Liu is a Professor, in Department of Diabetes and Metabolic Diseases and Department of Immunology, at Beckman Research Institute of City of Hope. He received his B.S. degree from National Taiwan University, and Ph.D. degree from University of Wisconsin-Madison, followed by postdoctoral fellowships at Beth Israel Hospital/Harvard Medical School in Boston and at National Jewish Medical and Research Center in Denver. He has had long-standing research interest in understanding the mechanisms that regulate immune tolerance induction during type 1 diabetes development. His recent work has focused on using genome-wide approaches to understand the molecular mechanisms responsible for modulating the function of regulatory T cells and identifying gene targets to improve regulatory T cell function for immunotherapy.